In a week marked by cautious Federal Reserve commentary and looming political uncertainties, global markets experienced notable fluctuations, with U.S. stocks facing broad-based declines despite a late-week rally. As investors navigate these turbulent waters, dividend stocks often appeal for their potential to provide steady income streams amidst market volatility. When considering what makes a good dividend stock in such an environment, it's crucial to look for companies with strong financial health and consistent dividend payment histories. In this article, we explore Cosmo Pharmaceuticals and two other noteworthy dividend stocks that may offer stability and income opportunities during uncertain times.

Top 10 Dividend Stocks

Click here to see the full list of 1951 stocks from our Top Dividend Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Overview: Cosmo Pharmaceuticals N.V. is engaged in the development and commercialization of products for gastroenterology, dermatology, and healthtech globally, with a market cap of CHF982.01 million.

Operations: Cosmo Pharmaceuticals N.V. generates its revenue primarily from its pharmaceuticals segment, amounting to €185.36 million.

Dividend Yield: 3.1%

Cosmo Pharmaceuticals' dividend payments have been volatile over the past decade, although they are well-covered by earnings and cash flows, with payout ratios of 46.2% and 32.8%, respectively. The dividend yield of 3.06% is below the top tier in the Swiss market, but the company trades at a good value compared to peers. Recent executive appointments signal a strategic focus on growth and innovation, potentially impacting future financial stability and dividends positively.

Overview: Sanlien Technology Corp. manufactures and sells specialty chemicals for the semiconductor industry in Taiwan, Asia, and internationally, with a market cap of NT$3.40 billion.